Citation

BibTex format

@article{Hedberg:2015:10.1007/s11095-015-1758-3,
author = {Hedberg, SHM and Heng, JYY and Williams, DR and Liddel, JM},
doi = {10.1007/s11095-015-1758-3},
journal = {Pharmaceutical Research},
pages = {3975--3985},
title = {Self-interaction chromatography of mAbs: accurate measurement of dead volumes},
url = {http://dx.doi.org/10.1007/s11095-015-1758-3},
volume = {32},
year = {2015}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Purpose: Measurement of the second virial coefficient B22 for proteins using self-interaction chromatography (SIC) is becoming an increasingly important technique for studying their solution behaviour. In common with all physicochemical chromatographic methods, measuring the dead volume of the SIC packed column is crucial for accurate retention data; this paper examines best practise for dead volume determination.Method: SIC type experiments using catalase, BSA, lysozyme and a mAb as model systems are reported, as well as a number of dead column measurements. Results: It was observed that lysozyme and mAb interacted specifically with Toyopearl AF-Formyl dead columns depending upon pH and [NaCl], invalidating their dead volume usage. Toyopearl AF-Amino packed dead columns showed no such problems and acted as suitable dead columns without any solution condition dependency. Dead volume determinations using dextran MW standards with protein immobilised SIC columns provided dead volume estimates close to those obtained using Toyopearl AF-Amino dead columns. Conclusion: It is concluded that specific interactions between proteins, including mAbs, and select SIC support phases can compromise the use of some standard approaches for estimating the dead volume of SIC columns. Two other methods were shown to provide good estimates for the dead volume.
AU - Hedberg,SHM
AU - Heng,JYY
AU - Williams,DR
AU - Liddel,JM
DO - 10.1007/s11095-015-1758-3
EP - 3985
PY - 2015///
SN - 1573-904X
SP - 3975
TI - Self-interaction chromatography of mAbs: accurate measurement of dead volumes
T2 - Pharmaceutical Research
UR - http://dx.doi.org/10.1007/s11095-015-1758-3
UR - http://hdl.handle.net/10044/1/25786
VL - 32
ER -